Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 2
2008 2
2009 5
2010 13
2011 19
2012 20
2013 14
2014 9
2015 8
2016 7
2017 10
2018 10
2019 18
2020 14
2021 16
2022 36
2023 27
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, van Rooij N, van Leerdam ME, Depla A, Smit EF, Hartemink KJ, de Groot R, Wolkers MC, Sachs N, Snaebjornsson P, Monkhorst K, Haanen J, Clevers H, Schumacher TN, Voest EE. Dijkstra KK, et al. Among authors: van leerdam me. Cell. 2018 Sep 6;174(6):1586-1598.e12. doi: 10.1016/j.cell.2018.07.009. Epub 2018 Aug 9. Cell. 2018. PMID: 30100188 Free PMC article.
Hereditary pancreatic cancer.
Klatte DCF, Wallace MB, Löhr M, Bruno MJ, van Leerdam ME. Klatte DCF, et al. Among authors: van leerdam me. Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101783. doi: 10.1016/j.bpg.2021.101783. Epub 2022 Jan 3. Best Pract Res Clin Gastroenterol. 2022. PMID: 35988957 Free article. Review.
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, Grootscholten C, Beets GL, Snaebjornsson P, Maas M, Mertz M, Veninga V, Bounova G, Broeks A, Beets-Tan RG, de Wijkerslooth TR, van Lent AU, Marsman HA, Nuijten E, Kok NF, Kuiper M, Verbeek WH, Kok M, Van Leerdam ME, Schumacher TN, Voest EE, Haanen JB. Chalabi M, et al. Among authors: van leerdam me. Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6. Nat Med. 2020. PMID: 32251400 Clinical Trial.
Preface Hereditary disorders.
van Leerdam ME, Ricciardiello L. van Leerdam ME, et al. Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101801. doi: 10.1016/j.bpg.2022.101801. Epub 2022 Jul 5. Best Pract Res Clin Gastroenterol. 2022. PMID: 35988961 No abstract available.
Reply.
Kooyker AI, Lansdorp-Vogelaar I, Van Leerdam ME. Kooyker AI, et al. Among authors: van leerdam me. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1418-1419. doi: 10.1016/j.cgh.2021.09.012. Epub 2021 Sep 15. Clin Gastroenterol Hepatol. 2022. PMID: 34536582 No abstract available.
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.
Verschoor YL, van de Haar J, van den Berg JG, van Sandick JW, Kodach LL, van Dieren JM, Balduzzi S, Grootscholten C, IJsselsteijn ME, Veenhof AAFA, Hartemink KJ, Vollebergh MA, Jurdi A, Sharma S, Spickard E, Owers EC, Bartels-Rutten A, den Hartog P, de Miranda NFCC, van Leerdam ME, Haanen JBAG, Schumacher TN, Voest EE, Chalabi M. Verschoor YL, et al. Among authors: van leerdam me. Nat Med. 2024 Feb;30(2):519-530. doi: 10.1038/s41591-023-02758-x. Epub 2024 Jan 8. Nat Med. 2024. PMID: 38191613 Free PMC article. Clinical Trial.
196 results